1. Home
  2. Investing
  3. Quotes
  4. Stocks
  5. Germany
  6. MOR
  7. Overview
    |
    MOR Germany: Xetra

    MorphoSys AG

    Watchlist
    NEW
    Set a price target alert
    MORXE
    Open
    Last Updated: Feb 2, 2024 10:19 a.m. CEST Delayed quote

    € 43.61

    2.99 7.36%
    Previous Close
    €40.62
    Advanced Charting
    Volume: 230.4K 65 Day Avg: 662.68K
    35% vs Avg
    41.56 Day Range 44.08
    13.45 52 Week Range 44.08

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Create Account … or Log In
    Symbol
    Company
    Price
    Chg/Chg %
    (Go to Your Watchlist)
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Add Tickers
    No Saved Watchlists

    Create a list of the investments you want to track.

    Create Watchlist …or learn more
    Uh oh

    Something went wrong while loading Watchlist.

    Go to Watchlist

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    Overview

  • Overview
  • Profile
  • Charts
  • Financials
  • Historical Quotes
  • Premium Tools

    • MOR Overview

    Key Data

    • Open €41.99
    • Day Range 41.56 - 44.08
    • 52 Week Range 13.45 - 44.08
    • Market Cap €1.48B
    • Shares Outstanding 37.66M
    • Public Float 37.58M
    • Beta 0.86
    • Rev. per Employee €403.18K
    • P/E Ratio 16.29
    • EPS €2.68
    • Yield N/A
    • Dividend N/A
    • Ex-Dividend Date N/A
    • Short Interest N/A
    • % of Float Shorted N/A
    • Average Volume 662.68K

    Performance

    5 Day
    • 6.70%
    1 Month
    • 23.09%
    3 Month
    • 43.41%
    YTD
    • 28.26%
    1 Year
    • 129.53%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 13 Full Ratings

    Recent News

    US Futures Flat, European Stocks Slightly Down Ahead of Central Bank Decisions

    Jan. 29, 2024 at 3:33 a.m. ET

    European stocks extend positive streak for third session

    Jan. 26, 2024 at 12:00 p.m. ET by MarketWatch Automation

    US Futures, European Stocks Rise Ahead of U.S. Inflation Data

    Jan. 11, 2024 at 3:35 a.m. ET

    US Futures, European Stocks Climb

    Jan. 2, 2024 at 3:35 a.m. ET

    U.S. Futures Decline, European Stocks Mostly Down

    Dec. 22, 2023 at 3:37 a.m. ET

    MorphoSys Shares Fall After Raising Funds to Accelerate Drug Launch, Trials

    Dec. 14, 2023 at 6:59 a.m. ET

    MorphoSys Shares Rise 29% On Data From Myelofibrosis Treatment Trial

    Dec. 11, 2023 at 12:09 p.m. ET

    US Futures Edge Down, European Stocks Mixed

    Dec. 11, 2023 at 3:34 a.m. ET

    US Futures Flat, European Stocks Gain Ahead of Regional PMI Data and US Federal Reserve Chair's Speech

    Dec. 1, 2023 at 3:34 a.m. ET

    US Futures, European Stocks Fall as Investors Await Fresh Cues

    Nov. 28, 2023 at 3:34 a.m. ET

    US Futures Mixed, European Stocks Up Ahead of Thanksgiving

    Nov. 22, 2023 at 3:36 a.m. ET

    US Futures Flat, European Stocks Mixed

    Nov. 21, 2023 at 3:33 a.m. ET

    Stocks to Watch: Symbotic, MorphoSys, Agilent Technologies

    Nov. 20, 2023 at 6:48 p.m. ET

    MorphoSys Trial for Blood-Cancer Treatment Reaches Primary Endpoint

    Nov. 20, 2023 at 4:49 p.m. ET

    MorphoSys shares plunge after partner Roche says Alzheimer's drug trials didn't meet goals

    German-listed shares of MorphoSys lost a third of their value on Monday after its partner Roche said an Alzheimer drug trial failed. Roche slumped 4% in Zurich as the company said Phase 3 studies evaluating gantenerumab ...

    Nov. 14, 2022 at 5:22 a.m. ET by Steve Goldstein

    Buy Rating on Morphosys Ag Backed by Pelabresib’s Breakthrough Efficacy in Myelofibrosis Treatment

    Dec. 11, 2023 at 4:35 p.m. ET on TipRanks.com

    JMP Securities Remains a Buy on Morphosys Ag (MOR)

    Aug. 10, 2023 at 2:25 p.m. ET on TipRanks.com

    JMP Securities Keeps Their Buy Rating on Morphosys Ag (MOR)

    Jun. 22, 2023 at 12:25 a.m. ET on TipRanks.com

    JMP Securities Keeps Their Buy Rating on Morphosys Ag (MOR)

    Apr. 5, 2023 at 12:25 a.m. ET on TipRanks.com

    MorphoSys AG

    MorphoSys AG operates as a commercial-stage biopharmaceutical company. It uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. The firm also engages in the development and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.

    Competitors

    Name Chg % Market Cap
    Johnson & Johnson -0.34% $382.52B
    Eli Lilly & Co. 2.30% $612.88B
    Merck & Co. Inc. 4.64% $306.06B
    AbbVie Inc. 1.94% $290.25B
    Roche Holding AG Akt -5.65% CHF199.35B
    Roche Holding AG -5.50% CHF199.35B
    Pfizer Inc. 0.78% $152.9B
    Novartis AG 1.28% CHF184.9B
    Bristol Myers Squibb Co. -0.41% $99.44B
    MedicalSystem Biotechnology Co. Ltd. A -1.41% ¥3.54B